COVID-19 booster | Chronic pain | Lyme disease

National Institutes of Health (NIH) sent this bulletin at 11/02/2021 02:00 PM EDT

Having trouble viewing this email? View it as a Web page.

November 2, 2021 Edition

We at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines for COVID-19. You can find the latest public health information from CDC at https://www.cdc.gov/coronavirus and the latest research information from NIH at https://www.covid19.nih.gov. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics.

Nurse giving vaccination to senior person

Moderna COVID-19 booster may protect against variants

A booster of the Moderna COVID-19 vaccine increased levels of neutralizing antibodies against all variants of concern in a primate study.

Young woman standing and holding back while working on laptop at home

Retraining the brain to treat chronic pain

After a treatment called pain reprocessing therapy, two-thirds of people with mild or moderate chronic back pain reported being mostly or completely pain-free.

Photograph of a mouse eating a piece of bait

A targeted antibiotic for treating Lyme disease

Researchers found that a neglected antibiotic called hygromycin A selectively kills the bacteria that cause Lyme disease.

Connect with us:

Facebook

RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website.